This paper measures differences in the innovation performance of different types of firms in the pharmaceutical industry. We compare the innovation performance of incumbent firms with entrants, controlling for differences in the scale and scope of research, both at the firm level and at the...

This paper estimates the "production function" for scientific research publications in the field of biotechnology. it utilises an exceptionally rich and comprehensive data set pertaining to the universe of research groups that applied to a 1989-1993 research programme in biotechnology and...

We analyze the effect of patenting on R&D with a model linking a firm's R&D effort with its decision to patent, recognizing that R&D and patenting affect one another and are both driven by many of the same factors. Using survey data for the U.S. manufacturing sector, we estimate the increment to...

The merger of distributed object technology, agent systems and electronic commerce enables a new generation of useful information services. With the advent of interoperable information services, markets featuring software agents as information service/product providers can be created. Meta...

This paper explored an unusually comprehensive dataset of more than 2,000 drug R&D projects all over the world during the 1990s. This enabled us to characterise several features of the innovation process in pharmaceuticals, particularly the different role and comparative R&D performance of the...

In technology-based industries, incumbent firms often license their technology to other firms that will potentially compete with them. Such a strategy is difficult to explain within traditional models of licensing. This paper extends the literature on licensing by relaxing the assumption of a...